Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Apr 16, 2022
Date Accepted: Aug 22, 2022
Date Submitted to PubMed: Aug 25, 2022

The final, peer-reviewed published version of this preprint can be found here:

The Disparities in Patient Portal Use Among Patients With Rheumatic and Musculoskeletal Diseases: Retrospective Cross-sectional Study

Sun EY, Alvarez C, Callahan LF, Sheikh SZ

The Disparities in Patient Portal Use Among Patients With Rheumatic and Musculoskeletal Diseases: Retrospective Cross-sectional Study

J Med Internet Res 2022;24(8):e38802

DOI: 10.2196/38802

PMID: 36001872

PMCID: 9439379

Disparities in Patient Portal Use Among Patients with Rheumatic and Musculoskeletal Diseases: A Retrospective Cross-Sectional Study

  • Enid Y Sun; 
  • Carolina Alvarez; 
  • Leigh F Callahan; 
  • Saira Z Sheikh

ABSTRACT

Background:

During the COVID-19 pandemic, the shift to virtual care became essential for the continued care of patients. Individuals with rheumatic and musculoskeletal diseases (RMDs) especially require frequent provider visits and close monitoring. To date, there have been limited studies examining inequities in health technology use among patients with RMDs.

Objective:

Our goal is to identify characteristics associated with patient portal use before and after COVID-19 in a convenience sample of RMD patients from a large academic medical center.

Methods:

In this cross-sectional study, Epic electronic medical record data were queried to identify established patients of the University of North Carolina Hospitals adult rheumatology clinic between November 1, 2017 through November 30, 2019. Demographic and clinical data were collected to compare MyChart (Epic’s patient portal) users with non-users before and after the COVID-19 pandemic. MyChart activation and use were modeled using logistic regression and adjusted odds ratios and confidence intervals were estimated.

Results:

We identified 5075 established patients with RMDs who met the inclusion criteria. Prior to the pandemic, we found that younger age (P<.001), suburban residence (P=.0498), commercial/state insurance (P<.001), military insurance (P=.0498), and median income >$50,000 (P<.001) were associated with significantly higher odds of MyChart activation. Male sex (P<.001), Black/African American or “other” race (P<.001), Spanish as primary language (P<.001), rural residence (P=0.007), Medicaid insurance (P<.001), and median income <$25,000 (P=.01) was associated with lower odds of MyChart activation. Following COVID-19, younger age (P<.001), commercial insurance (P=.03), state insurance (P=.02), and median income $50,000-<$75,000 (P=.01) were associated with significantly higher odds of MyChart use. However, Black/African American race (P<.001) or “other” race (P=.01), Spanish as primary language (P=.002), male sex (P=.004), rural residence (P=.005), and having no insurance (P<.001) or Medicaid (P=.008) were associated with lower odds of MyChart use.

Conclusions:

Residence in a rural area, minority race/ethnicity, older age, male sex, lower median income, Medicaid, being uninsured, and non-English primary language are associated with lower odds of patient portal activation and use. Future health policy and clinical practice measures should focus on reducing barriers to health technology adoption among these groups.


 Citation

Please cite as:

Sun EY, Alvarez C, Callahan LF, Sheikh SZ

The Disparities in Patient Portal Use Among Patients With Rheumatic and Musculoskeletal Diseases: Retrospective Cross-sectional Study

J Med Internet Res 2022;24(8):e38802

DOI: 10.2196/38802

PMID: 36001872

PMCID: 9439379

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.